title: Antibody proteases: induction of catalytic response.
abstract: Most of the data accumulated throughout the years on investigation of catalytic antibodies indicate that their production increases on the background of autoimmune abnormalities. The different approaches to induction of catalytic response toward recombinant gp120 HIV-1 surface protein in mice with various autoimmune pathologies are described. The peptidylphosphonate conjugate containing structural part of gp120 molecule is used for reactive immunization of NZB/NZW F1, MRL, and SJL mice. The specific modification of heavy and light chains of mouse autoantibodies with Val-Ala-Glu-Glu-Glu-Val-PO(OPh)2 reactive peptide was demonstrated. Increased proteolytic activity of polyclonal antibodies in SJL mice encouraged us to investigate the production of antigen-specific catalytic antibodies on the background of induced experimental autoimmune encephalomyelitis (EAE). The immunization of autoimmune-prone mice with the engineered fusions containing the fragments of gp120 and encephalitogenic epitope of myelin basic protein (MBP(89-104)) was made. The proteolytic activity of polyclonal antibodies isolated from the sera of autoimmune mice immunized by the described antigen was shown. Specific immune response of SJL mice to these antigens was characterized. Polyclonal antibodies purified from sera of the immunized animals revealed proteolytic activity. The antiidiotypic approach to raise the specific proteolytic antibody as an "internal image" of protease is described. The "second order" monoclonal antibodies toward subtilisin Carlsberg revealed pronounced proteolytic activity.
authors.affiliation: Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, 117198 Russia. gabibov@ibch.ru
authors.forename: A G
authors.initials: AG
authors.lastname: Gabibov
authors.forename: A
authors.initials: A
authors.lastname: Friboulet
authors.forename: D
authors.initials: D
authors.lastname: Thomas
authors.forename: A V
authors.initials: AV
authors.lastname: Demin
authors.forename: N A
authors.initials: NA
authors.lastname: Ponomarenko
authors.forename: I I
authors.initials: II
authors.lastname: Vorobiev
authors.forename: D
authors.initials: D
authors.lastname: Pillet
authors.forename: M
authors.initials: M
authors.lastname: Paon
authors.forename: E S
authors.initials: ES
authors.lastname: Alexandrova
authors.forename: G B
authors.initials: GB
authors.lastname: Telegin
authors.forename: A V
authors.initials: AV
authors.lastname: Reshetnyak
authors.forename: O V
authors.initials: OV
authors.lastname: Grigorieva
authors.forename: N V
authors.initials: NV
authors.lastname: Gnuchev
authors.forename: K A
authors.initials: KA
authors.lastname: Malishkin
authors.forename: D D
authors.initials: DD
authors.lastname: Genkin
mesh_terms: D000818:Animals; D000888:Antibodies, Anti-Idiotypic / Q000097:blood / Q000276:immunology / Q000302:isolation & purification / Q000378:metabolism; D017151:Antibodies, Catalytic / Q000097:blood / Q000276:immunology / Q000302:isolation & purification / Q000378:metabolism*; D001327:Autoimmune Diseases / Q000276:immunology; D015153:Blotting, Western; D002384:Catalysis; D010450:Endopeptidases / Q000097:blood / Q000276:immunology / Q000302:isolation & purification / Q000378:metabolism*; D004790:Enzyme Induction; D004797:Enzyme-Linked Immunosorbent Assay; D004925:Escherichia; D007114:Immunization; D007700:Kinetics; D051379:Mice; D015394:Molecular Structure
chemical_list: D000888:Antibodies, Anti-Idiotypic; D017151:Antibodies, Catalytic; D010450:Endopeptidases